ProMIS Neurosciences (TSX:PMN) YoY EBITDA Growth : 53.46% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is ProMIS Neurosciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. ProMIS Neurosciences's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 53.46%.

ProMIS Neurosciences's EBITDA per Share for the three months ended in Dec. 2023 was C$-0.55.

ProMIS Neurosciences YoY EBITDA Growth Historical Data

The historical data trend for ProMIS Neurosciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProMIS Neurosciences YoY EBITDA Growth Chart

ProMIS Neurosciences Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

31.58

30.70

-73.15

-55.86

36.87

ProMIS Neurosciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															-214.78	-131.29	24.57	67.39	53.46

ProMIS Neurosciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

ProMIS Neurosciences's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-2.031	-	-3.217)	/	\| -3.217 \|
=	36.87 %

ProMIS Neurosciences's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-0.545	-	-1.171)	/	\| -1.171 \|
=	53.46 %

ProMIS Neurosciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of ProMIS Neurosciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

ProMIS Neurosciences (TSX:PMN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProMIS Neurosciences Inc (TSX:PMN) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

PMN:USA 23J0:Germany

Address

1920 Yonge Street, Suite 200, Toronto, ON, CAN, M4S 3E2

Website

https://www.promisneurosciences.com

ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson's disease, and dementia with Lewy bodies. It operates in Canada.